AHA Scientific Sessions 2026 Abstract
Respiratory syncytial virus vaccine showed similar effectiveness
Compared with no vaccination, estimated effectiveness against virus-related respiratory hospitalization was 100% with neurological or cerebrovascular disease (zero versus…Compared with no vaccination, estimated effectiveness against virus-related respiratory hospitalization was 100% with neurological or cerebrovascular disease (zero versus one event) and 82.4% without.
Randomized trialLung
Who was studiedAdults aged 60 years or older
What changedVaccine effectiveness against RSV-related respiratory hospitalization was similar: 100% with neurological/cerebrovascular disease versus 82.4% without
The catchOnly one RSV-related respiratory hospitalization occurred among participants with neurological or cerebrovascular disease